Alnylam Pharmaceuticals
ALNY
#544
Rank
NZ$73.23 B
Marketcap
NZ$552.21
Share price
-3.29%
Change (1 day)
17.39%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company